FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511887022> ?p ?o ?g. }

• W2511887022 endingPage "1472" @default.
• W2511887022 startingPage "1461" @default.
• W2511887022 abstract "Background In the pediatric cancer neuroblastoma (NB), patients are stratified into low, intermediate or high‐risk subsets based in part on MYCN amplification status. While MYCN amplification in general predicts unfavorable outcome, no clinical or genomic factors have been identified that predict outcome within these cohorts of high‐risk patients. In particular, it is currently not possible at diagnosis to determine which high‐risk neuroblastoma patients will ultimately fail upfront therapy. Experimental design We analyzed the prognostic potential of most published gene expression signatures for NB and developed a new prognostic signature to predict outcome for patients with MYCN amplification. Network and pathway analyses identified candidate therapeutic targets for this MYCN‐amplified patient subset with poor outcome. Results Most signatures have a high capacity to predict outcome of unselected NB patients. However, the majority of published signatures, as well as most randomly generated signatures, are highly confounded by MYCN amplification, and fail to predict outcome in subpopulations of high‐risk patients with MYCN‐amplified NB. We identify a MYCN module signature that predicts patient outcome for those with MYCN‐amplified tumors, that also predicts potential tractable therapeutic signaling pathways and targets including the DNA repair enzyme Poly [ADP‐ribose] polymerase 1 (PARP1). Conclusion Many prognostic signatures for NB are confounded by MYCN amplification and fail to predict outcome for the subset of high‐risk patients with MYCN amplification. We report a MYCN module signature that is associated with distinct patient outcomes, and predicts candidate therapeutic targets in DNA repair pathways, including PARP1 in MYCN‐amplified NB." @default.
• W2511887022 created "2016-09-16" @default.
• W2511887022 creator A5039311333 @default.
• W2511887022 creator A5045886444 @default.
• W2511887022 creator A5054707090 @default.
• W2511887022 creator A5083061371 @default.
• W2511887022 date "2016-08-18" @default.
• W2511887022 modified "2023-10-12" @default.
• W2511887022 title "Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma" @default.
• W2511887022 cites W145418528 @default.
• W2511887022 cites W1546483925 @default.
• W2511887022 cites W1753717414 @default.
• W2511887022 cites W1923479395 @default.
• W2511887022 cites W1993893966 @default.
• W2511887022 cites W2010111403 @default.
• W2511887022 cites W2011795445 @default.
• W2511887022 cites W2012404242 @default.
• W2511887022 cites W2013276712 @default.
• W2511887022 cites W2016306999 @default.
• W2511887022 cites W2022397091 @default.
• W2511887022 cites W2023587649 @default.
• W2511887022 cites W2024280594 @default.
• W2511887022 cites W2024963052 @default.
• W2511887022 cites W2028518402 @default.
• W2511887022 cites W2030472644 @default.
• W2511887022 cites W2030646897 @default.
• W2511887022 cites W2041043497 @default.
• W2511887022 cites W2044033792 @default.
• W2511887022 cites W2049942970 @default.
• W2511887022 cites W2054013802 @default.
• W2511887022 cites W2057957210 @default.
• W2511887022 cites W2058539819 @default.
• W2511887022 cites W2064013031 @default.
• W2511887022 cites W2080041412 @default.
• W2511887022 cites W2081368063 @default.
• W2511887022 cites W2095849686 @default.
• W2511887022 cites W2096398040 @default.
• W2511887022 cites W2097120541 @default.
• W2511887022 cites W2098282574 @default.
• W2511887022 cites W2104096565 @default.
• W2511887022 cites W2104593681 @default.
• W2511887022 cites W2106713259 @default.
• W2511887022 cites W2107665951 @default.
• W2511887022 cites W2109378990 @default.
• W2511887022 cites W2110417418 @default.
• W2511887022 cites W2111437716 @default.
• W2511887022 cites W2123471907 @default.
• W2511887022 cites W2125290561 @default.
• W2511887022 cites W2129688634 @default.
• W2511887022 cites W2130492852 @default.
• W2511887022 cites W2130925781 @default.
• W2511887022 cites W2132546867 @default.
• W2511887022 cites W2132604294 @default.
• W2511887022 cites W2137904520 @default.
• W2511887022 cites W2138669911 @default.
• W2511887022 cites W2138983295 @default.
• W2511887022 cites W2139004454 @default.
• W2511887022 cites W2142354018 @default.
• W2511887022 cites W2149034978 @default.
• W2511887022 cites W2150823346 @default.
• W2511887022 cites W2152420890 @default.
• W2511887022 cites W2156509269 @default.
• W2511887022 cites W2159621438 @default.
• W2511887022 cites W2161954865 @default.
• W2511887022 cites W2169703537 @default.
• W2511887022 cites W2170989872 @default.
• W2511887022 cites W2171432327 @default.
• W2511887022 cites W2218422691 @default.
• W2511887022 cites W2235405584 @default.
• W2511887022 cites W2254902182 @default.
• W2511887022 cites W4241801284 @default.
• W2511887022 doi "https://doi.org/10.1016/j.molonc.2016.07.012" @default.
• W2511887022 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5423212" @default.
• W2511887022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27599694" @default.
• W2511887022 hasPublicationYear "2016" @default.
• W2511887022 type Work @default.
• W2511887022 sameAs 2511887022 @default.
• W2511887022 citedByCount "11" @default.
• W2511887022 countsByYear W25118870222017 @default.
• W2511887022 countsByYear W25118870222018 @default.
• W2511887022 countsByYear W25118870222019 @default.
• W2511887022 countsByYear W25118870222021 @default.
• W2511887022 countsByYear W25118870222023 @default.
• W2511887022 crossrefType "journal-article" @default.
• W2511887022 hasAuthorship W2511887022A5039311333 @default.
• W2511887022 hasAuthorship W2511887022A5045886444 @default.
• W2511887022 hasAuthorship W2511887022A5054707090 @default.
• W2511887022 hasAuthorship W2511887022A5083061371 @default.
• W2511887022 hasBestOaLocation W25118870221 @default.
• W2511887022 hasConcept C104317684 @default.
• W2511887022 hasConcept C126322002 @default.
• W2511887022 hasConcept C143998085 @default.
• W2511887022 hasConcept C182979987 @default.
• W2511887022 hasConcept C2776715637 @default.
• W2511887022 hasConcept C2778480876 @default.
• W2511887022 hasConcept C502942594 @default.
• W2511887022 hasConcept C54355233 @default.
• W2511887022 hasConcept C60644358 @default.

• next